Tag: EKOS

SUNSET sPE thrombolysis trial presents interim analysis of ultrasound-guided versus standard...

The Standard vs ultrasound-assisted catheter thrombolysis for submassive pulmonary embolism (SUNSET sPE) trial, is an ongoing randomised, head-to-head, single-blinded clinical trial comparing ultrasound-assisted thrombolysis...

BTG to begin European distribution of EKOS Control unit 4.0

BTG has announced that the first EKOS Control Unit 4.0 have been shipped from BTG’s facility in Bothell (Washington, USA) to Europe, where full...

One-year results of ACCESS PTS study brings “hope” for post-thrombotic syndrome...

The one-year results of the ACCESS PTS trial have shown that EKOS therapy (BTG) statistically improves post-thrombotic syndrome scores and sequelae as well as...
KNOCOUT PE

Study to measure shorter duration EKOS therapy for pulmonary embolism is...

Global specialist healthcare company BTG has highlighted the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how hospitals and patients...

ACCESS PTS study demonstrates efficacy of EKOS therapy for post-thrombotic syndrome

The results of the ACCESS PTS trial have been presented at the Society for Vascular Medicine 28th Annual Scientific Sessions (14–17 June, New Orleans,...
Venous News

OPTALYSE PE study demonstrates safety and efficacy of shorter, lower dose...

Results from the OPTALYSE PE trial have been presented at the American Thoracic Society International Conference in Washington, DC, USA. The results show that...

First pulmonary embolism patients in Hong Kong treated with BTG’s EKOS...

The first Hong Kong-based patients diagnosed with pulmonary embolism have been treated using the newly available BTG EKOS system. The EKOS system includes an...